Clinical repercussions of the therapeutic use of cannabis derivatives in rheumatoid arthritis and osteoarthritis

Authors

DOI:

https://doi.org/10.33448/rsd-v11i9.31642

Keywords:

Cannabis; Rheumatoid Arthritis; Osteoarthritis.

Abstract

Introduction: Chronic inflammatory conditions related to joints are a source of intense daily suffering. The reduction in the life quality of its patients and the working capacity of some are related to intense pain and deterioration of the tissues that compose the cartilage by cells of the immune system. Cannabinoids have gained considerable relevance as objects of study regarding their vast applicable properties to pharmacological therapies, including anti-inflammatory and analgesic effects. This article aims to analyze the academic production on the implication of the use of cannabinoids as therapy in rheumatoid arthritis and osteoarthritis. Methodology: 5 articles were selected from the Virtual Health Library, published between 2017 and 2021, to compose this Integrative Literature Review. Discussion: In particular, cannabidiol has been shown to act upon receptors that participate in cellular pathways related to pain regulation and that delay the destructive process of affected tissues. The use of Cannabis derivatives for therapeutic purposes has gained great adherence, especially in countries where there is already legislation which allows it, especially by people living with chronic neuropathic pain. Conclusions: Pain control is the most emphasized symptom in the literature, due it’s impact on life quality of those affected. There is great interest from the scientific community in the advancement of cannabinoid study techniques. In parallel, people affected by diseases that could possibly benefit from cannabinoids therapeutic effects have sought them as an alternative to regularly prescribed drugs.

References

Bruce, D. et al (2018). Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses. J Altern Complement Med, 24(2). https://doi.org/10.1089/acm.2017.0184

Couch, D. G., Cook, H., Ortori, C., Barrett, D., Lund, J. N., & O'Sullivan, S. E. (2019). Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial. Inflammatory bowel diseases, 25(6), 1006–1018. https://doi.org/10.1093/ibd/izz017

Ferreira, L. N., Ferreira, P. L., & Baleiro, R. R. (2008). Qualidade de vida em doentes com Artrite Reumatóide [Health-related quality of life in patients with rheumatoid arthritis]. Acta reumatologica portuguesa, 33(3), 331–342.

Fones, L. et al (2022). Hand Surgery Patient Perspectives on Medical Cannabis: A Survey of Over 600 Patients. Journal of Hand Surgery Global Online, 1-6.

Grace, P. M., Hutchinson, M. R., Maier, S. F., & Watkins, L. R. (2014). Pathological pain and the neuroimmune interface. Nature reviews. Immunology, 14(4), 217–231. https://doi.org/10.1038/nri3621"

Harth, M., & Nielson, W. R. (2019). Pain and affective distress in arthritis: relationship to immunity and inflammation. Expert review of clinical immunology, 15(5), 541–552. https://doi.org/10.1080/1744666X.2019.1573675

Kaur, I. et al (2020). The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis. Life Sciences, (257). https://doi.org/10.1016/j.lfs.2020.118109

Lowin, T. et al (2020). Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts. Cell Death Dis, 8(11). https://doi.org/https://dx.doi.org/10.1038/s41419-020-02892-1

Mendes, K. D. S. et al (2008). Revisão Integrativa: Método de pesquisa para a incorporação de evidência na saúde e na enfermagem. Texto Contexto Enferm, 17(4), 758-64.

Mrid, R. B.et al (2022). Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis. Biomedicine & Pharmacotherapy, (151). https://doi.org/10.1016/j.biopha.2022.113126

Philpott, H. et al (2017). Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain, 158(12). https://doi.org/10.1097/j.pain.0000000000001052

Prospéro-García, O., Ruiz Contreras, A. E., Ortega Gómez, A., Herrera-Solís, A., Méndez-Díaz, M., & Grupo de Neurociencias de la Universidad Nacional Autónoma de México (2019). Endocannabinoids as Therapeutic Targets. Archives of medical research, 50(8), 518–526. https://doi.org/10.1016/j.arcmed.2019.09.005

Rother, E. T. (2007). Revisão sistemática X revisão narrativa. Acta paulista de enfermagem, 20(2), 5-6.

Sampaio, R. F., & Mancini, M. C. (2007). Systematic review studies: a guide for careful synthesis of the scientific evidence. Brazilian Journal of Physical Therapy, 11(1), 83-89.

Sociedade Brasileira de Neurologia . (2021). Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology. Arq. Neuro-Psiquiatr, 79(04), 354-369.

Shebaby, W. et al (2021). In vivo and in vitro anti-inflammatory activity evaluation of Lebanese Cannabis sativa L. ssp. indica (Lam.). J Ethnopharmacol, (270). https://doi.org/10.1016/j.jep.2020.113743

Simon, L. S. et al (2021). The Jak/STAT pathway: A focus on pain in rheumatoid arthritis. Seminars in arthritis and rheumatism, 51(1), 278–284. https://doi.org/10.1016/j.semarthrit.2020.10.008

Souza, M. T. et al (2010). Revisão integrativa: o que é e como fazer. Einstein, 1(8). https://doi.org/10.1590/S1679-45082010RW1134

Teixeira, F. M. et al (2013). Metodologias de pesquisa no ensino de ciências na América Latina. Ciência & Educação, 19(1), 15–33.

Verrico, C. D. et al (2020). A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain. Pain, 161(9). https://doi.org/https://dx.doi.org/10.1097/j.pain.0000000000001896

Downloads

Published

08/07/2022

How to Cite

MENDES, L. F. da S. .; RIBEIRO, G. de V. P. .; MOURA , P. R. S. e S. .; SILVA , L. S. A. da .; CRUZ, L. de O. .; LIMA, C. S. . .; SOUSA, L. L. de .; PIAUILINO, B. C. N. .; COÊLHO , A. J. M. N. .; BATISTA, I. L. de S. .; NOGUEIRA, M. G. S. . Clinical repercussions of the therapeutic use of cannabis derivatives in rheumatoid arthritis and osteoarthritis. Research, Society and Development, [S. l.], v. 11, n. 9, p. e23311931642, 2022. DOI: 10.33448/rsd-v11i9.31642. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/31642. Acesso em: 24 apr. 2024.

Issue

Vol. 11 No. 9

Section

Health Sciences

License

Copyright (c) 2022 Lucas Ferrari da Silva Mendes; Gabriel de Vasconcelos Pessoa Ribeiro; Paulo Ricardo Sousa e Silva Moura ; Lucas Solano Araújo da Silva ; Lívia de Oliveira Cruz; Clarice Sousa Lima; Lourivan Leal de Sousa; Bárbara Cândida Nogueira Piauilino; Antônio José Marques Nogueira Coêlho ; Ian Lucas de Sousa Batista; Mateus Guilherme Santos Nogueira

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.